Repotrectinib
- Generic Name
- Repotrectinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18FN5O2
- CAS Number
- 1802220-02-5
- Unique Ingredient Identifier
- 08O3FQ4UNP
- Indication
用于ROS1阳性的局部晚期或转移性非小细胞肺癌（NSCLC）成人患者。
- Associated Conditions
- -
- Associated Therapies
- -
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Instituto Oncológico Dr Rosell
- Target Recruit Count
- 32
- Registration Number
- NCT04772235
- Locations
- 🇪🇸
Hospital Regional Universitario de Málaga, Málaga, Andalucia, Spain
🇪🇸Hospital Son Espases, Palma, Baleares, Spain
🇪🇸Hospital Universitario Gregorio Marañón, Madrid, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath